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POSTER SESSION Conclusion: In women with chest pain, mild renal insufficiency is an independent predic- 
tor of significant angiographic CAD. Impaired creatinine clearance may be a marker for 
unmeasured pro-atherogenic factors. 
1003-115 Randomized Comparison of Fenoldopam and N- 
Acetylcysteine to Saline in the Prevention of Radio- 
Contrast Induced Nephropathy 
Emmanuel Loutrianakis , Dominick St&a, Atif Hussain. Bruce Lewis, Lowell Steen, Mirek 
Sochanski, Fred Leya. Eric Grassman. Loyola University Medical Center, Maywood, IL 
Introduction: 5% of patients undergoing cardiac angiography experience radio-contrast 
induced nephropathy @IN). This risk triples in patients with renal insufficiency. The cur- 
rently accepted prophylaxis is intravenous hydration (IVF) with 0.45 NS. Emerging evi- 
dence suggest N-acetylcystetne (NAG) and fenoldopam (FEN) may also have a 
protective role. 
Methods: Patients with creatinine (Cr) > 1.5 mg/dL who had a cardiac anglogram were 
randomized to one of three treatment groups: 1) IVF with 0.45 NS at t cclkgmr pre end 
post procedure, 2) IVF as above plus 600-mg BID of NAC the day prior to and on the day 
of procedure, 3) IVF as above plus FEN at 0.1 mcglkglmin starting 30 min prior to and 
continuing for 4 hrs post procedure. Cr levels were drawn prior to the angiogram and at 
5-7 days after the procedure. The primary end-point of the study was an increase in Cr of 
0.5 mg/dL or a 25% increase from baseline. Results: 68 patients with a mean age 67+10 
(24% females, 76% males) and a mean Cr level of 1.92+0.34 mg/dL were randomized 
into the three treatment groups of IVF only, NAC, and FEN. Baseline characteristics for 
the groups were similar. A statistically greater number of patients in the NAC group had 
an increase in baseline Cr > 25% as compared to the other two treatment groups (see 
Table 1). Conclusion: In patients with renal insuffiaency, hydration with 0.45NS alone is 
as effective as FEN plus hydration in preventing RIN. The combination of NAC and IVF 
was the least effective regimen. 
Table 1: Patients with an increase in Cr a1 5-7 days. 
Hydration NAC Fenoldopam P- 
(~23) (n-24) (n=21) value 
Increase in Cr > 0.5 rng/ 3 6 1 0.155 
dL 
Increase in Cr > 25% 2 8 2 0.043 
1003-l 16 A Simple Clinical Score Is an Accurate Prognostic 
Indicator in a Community-Based Population 
Todd D. Miller, Veronique L. Roger, David 0. Hodge, Raymond J. Gibbons, Mayo Clinic, 
Rochester, MN 
Introduction: Clinical scoring systems have been developed for initial assessment of 
patients with coronary artery disease (CAD) but are not widely applied due to their com- 
plexity and lack of validation. The purpose of this study was to validate a simple clinical 
prognostic score, originally developed in a cohort of patients referred to our nuclear car- 
diology laboratory. in a “less-selected” community-based population. 
Methods: The score was deslgned specifically to use a limited number of clinical vari- 
ables and an integer system to simplify calculation and recall: 1 point each for male gen- 
der, typical angina, diabetes, insulin use, hlstory of myocardial infarction (MI), and 1 point 
for each decade of age beginning at age 40 (40-49=1. 50s59=2, etc) (range of score 0 to 
9). The score was applied to all residents of Olmsted County, MN undergoing an initial 
exercise test between January 1987 and December 1990 (w3566). 
Results: Clinical characteristics included: age 50+15, male 64%, typical angina 8%. dia- 
betes 5%, insulin use 3%, history of Ml 10%. Follow-up was 7.6~2.7 yrs. Annual event 
rates were strongly associated with the score: overall mortality x&525, pcO.001; cardiac 
death $=192, p<O.OOl; cardiac death or Ml~c274. p<O.OOl (see table). 
Conclusion: This simple prognostic score was highly accurate for risk-stratifying this 
community population, supporting a more wide-spread application of this score in 
patients with CAD. 
Score Patients Overall Mortality Cardiac Death Cardiac Death/Ml 
<4 3076 (86%) 0.6% 0.2% 1 .O% 
5 275 (8%) 2.4% 0.8% 2.0% 
>6 215 (6%) 6.2% 2.8% 4.2% 
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1004-92 Paclitaxel Reduces Neointimal Formation In Vitro and in 
a Porcine Model of Saphenous Vein Interposition 
Grafting 
Martin H. Chamberlain, Thomas W. Johnson, Yin Xiong Wu, Jason L. Johnson, Andrew 
C. Newby, Gianni D. Angelini, Karl R. Karsch, Matim Oberhoff, Bristol Heart Institute, 
University of Bristol, Bristol, United Kingdom 
Background: Following early thrombosis, IO-15% of coronary vein grafts fail over the 
next 5 years due to intimal thickening. Paclitaxel is a potent inhibitor of cell proliferation 
by inducing a sustained block of mitosis at the metaphasslanaphase boundary. The aim 
of this study was to investigate the effect of paclitaxel pre-treatment in a porcine model of 
Saphenous vein to carotid artery interposition grafting. Methods: In-vitro evaluation of 
the eHect of short-term paclitaxel exposure on neointimal proliferation involved saphen- 
ous vein pre-treatment, by suspension in Paclitaxel (10 FmollL) or vehicle control, for 1 
hour, prior to plating and 14 day culture. Samples were histologically analysed. Subse- 
quently, ten Large White pigs (25-33.5 kg) underwent bilateral saphenous vein to carotid 
artery interposition grafting. Each animal received a Paclitaxel treated and a vehicle con- 
trol graft. Animals were sacrificed at 29 days, vein graHs were harvested and pressure 
fixed prior to histologicallmorphometric analysis. Results: In-vitro Paclitaxel exposure 
resulted in a significant reduction in neointimal thickness, compared with vehicle control; 
77.80+1-48.8Qm vs 148.35+1-82.73Fm (p=O.OOS). Only patent grafts were included in 
the in-viva analysis (see table). 
Parameter Control (n=8) Treated (n=8) P value 
Lumlnal Area (mm? 32.08i15.45 25.26e15.53 0.017 
Neointimal Area (m&) 2.43tl.35 1.59t0.95 0.0004 
Medial Area (mm’) 6.83e2.57 6.18k5.84 0.25 
NeointimallMedial Ratio 0.37+0.18 0.299+0.16 0.029 
Conclusion: Our data demonstrates that Paclitaxel pre-treatment reduces neointima for- 
mation, in-vitro and in-viva Paclitaxel may be a highly attractive candidate for prevention 
of late vein graft failure. 
1004-94 Functional Myocardial Angiogenesis Resulting From 
Persistent Systolic Perfusion 
Marvin J. Slepian, Michael J. Mooney, Donald C. Harrison, Robed W. Emery, Randall K. 
Wolf, Katherine S. Tweden, University of Arizona, Tucson, AZ, Mtnnaapolis Heart 
Institute, Minneapolis, MN 
Background: The effects of systolic perfusion on distal coronary bed myocardium were 
studied by using a device that creates a permanent transmyocardial flow channel 
between the left ventricle and a coronary artery (Ventriculocoronary Artery Bypass 
(VCAB) procedure). Methods: The stent-like direct revascularization device (DRD), an 
L-shaped titanium tube with a meshed distal tip, was implanted between the leftventricu- 
lar cavity and the mid left anterior descending coronary artery (LAD) in 15 juvenile 
domestic pigs using a beating heart approach. The LAD was ligated proximal to the 
device. Patency was assessed via retrograde anglography at explant for surviving ani- 
mals at 12 weeks (n=12). Morphometry of blood vessels (150 fields total) was assessed 
in the subendocardium using PAX-It TM software. Hearts retrieved acutely from pigs were 
used as controls. 
Results: 3/15 animals died within 24 hours related to procedural complications. At 12 
weeks, patency was achieved in 1 l/12 pigs. Morphometric assessment of the target 
myocardium showed a significant increase in number of small (25-200 pm), medium 
(200-4OOpm) and large (>40@m) arterioles compared to the control in the subendocar- 
dial region (see graph). Conclusions: This study demonstrates persistent patency of a 
